CClinicalTrials.gg
CompletedNCT05525494Updated Aug 7, 2024Results posted

Patient Portal Flu Vaccine Reminders (5)

An interventional study of Text Fixed R/R Messages with Direct Appointment Schedule Link and Text Pre-Appointment Reminder in Influenza and Respiratory Tract Infections, sponsored by University of California, Los Angeles. Completed at 1 site in United States. Open to participants aged 6 Months and older. Per ClinicalTrials.gov, last updated 2024-08-07.

Sponsored by University of California, Los Angeles · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
262,085
Allocation
Randomized
Ages
6 Months and older
Sex
All
01

Study summary

This trial is taking place in Los Angeles, CA at clinics within the UCLA Health System.

The study design is a 2x2 nested factorial design. Patients will be randomized into 1) receiving text based reminder messages with direct scheduling link, 2) portal-based reminder messages with direct scheduling link, or 3) the control group. Patients randomized to the intervention arms will receive reminders if they are due for influenza vaccine.

Nested within the portal reminder arm, we will have two additional components for which patients will be randomized separately:

  1. A pre-commitment prompt, asking patients which time (September, October, November or December) and which place (UCLA, pharmacy, workplace or school, or other) they plan to get their Influenza vaccine with tailored monthly messages based on responses (pre-commitment message with tailored recall messages with direct scheduling vs. standard portal reminders with direct scheduling).
  2. A pre-appointment reminder encouraging patients to ask for their influenza vaccine at their upcoming appointment (pre-appointment reminder encouraging influenza vaccination vs. standard pre-appointment reminder not mentioning influenza vaccination)

Nested within the text message reminder arm, we will have one additional component for which patients will be randomized separately:

  1. A pre-appointment reminder encouraging patients to ask for their influenza vaccine at their upcoming appointment (pre-appointment reminder encouraging influenza vaccination vs. standard pre-appointment reminder not mentioning influenza vaccination)

Despite the Advisory Committee on Immunization Practices (ACIP) recommendation in 2010 that all people above 6 months of age should receive an annual flu vaccine, vaccination rates remain low: at 6m-4.9 yrs. (70%), 5-17.9 yrs. (56%), 18-64.9 yrs. (38%), and >65 yrs. (63%). The investigators will assess the effectiveness of MyChart R/R messages and text R/R messages as compared to the standard of care control (no messages).

Read the detailed description

Sub-optimal vaccination rates are a significant problem in the U.S., despite their effectiveness in preventing morbidity and mortality from vaccine-preventable illness. For influenza specifically, annual epidemics of influenza cause substantial morbidity in the U.S. with up to 40,00-80,000 deaths/year and many hospitalizations, emergency and outpatient visits, and significant costs.

Reminder/recall (R/R), sent by phone, mail or other modality, can improve child and adult influenza vaccination rates. However, the majority of pediatric or adult primary care practices do not conduct R/R. Barriers are lack of finances, personnel, and algorithms to identify eligible patients.

A technological breakthrough that might overcome these barriers involves patient portals-- secure, web-based communication systems, embedded within electronic health records (EHRs), for patients and providers to communicate with each other via email and the internet. Portals are used by about half of Americans and half of UCLA patients. Another is text messaging at the health system level.

This randomized controlled trial will assess the effectiveness of reminders messages sent to portal users, encouraging influenza vaccination, on increasing influenza vaccination rates within a health system. Patients will be randomized into three groups: 1) one-third of patients will receive reminder messages with direct scheduling and pre-appointment reminders via the portal, 2) one-third will receive reminders via text messages with direct scheduling and pre-appointment reminders sent by the health system and 3) one-third will not receive reminders.

Patients in the portal-based reminder arm will be further randomized (separately) for two additional components: pre-commitment messages with tailored recall messages and pre-appointment reminders. Patients in the text message-based reminder arm will be further randomized for an additional component: pre-appointment reminders.

Direct scheduling: The convenience of scheduling an appointment for influenza vaccination may increase the likelihood that patients receive an influenza vaccination. All patients receiving reminders (intervention groups) will receive flu vaccine reminder letters with a link to the MyChart direct appointment scheduling page.

Pre-appointment flu reminders: Finally, a missed opportunities for vaccination occurs when patients are eligible for vaccination but are not offered a vaccine at their medical appointment. Pre-appointment reminders, sent in advance of an upcoming appointment, encouraging the patient talk to their doctor about influenza vaccination, may increase the likelihood of that patient receiving a vaccine. Patients in both the portal-based and text message-based reminder arms will be randomized to one of two groups: 1) one half will receive modified pre-appointment reminders that mention influenza vaccination and 2) one half will receive the standard pre-appointment reminders for an upcoming appointment (no mention of influenza vaccination).

Pre-commitment prompts with tailored monthly reminders: pre-planning the place and time of the flu vaccination may improve follow-through. A pre-commitment prompt will be sent via the portal in early September asking patients to commit to a time (September, October, November or December) and place (UCLA, pharmacy, workplace or school, or other) for their flu vaccination. Tailored monthly messages will be sent to patients based on their response to the pre-commitment prompt sent in September. Patients in the portal-based reminder arm will be randomized to one of two groups: 1) one half will receive the pre-commitment prompt and tailored monthly reminders, 2) one half will receive standard monthly reminders.

Interventions that apply Behavioral Economics principles in vaccine promotion messaging can increase vaccine receipt. We will include ownership language in the pre-appointment messages. The convenience of reminders sent via text and with a Direct Appointment Schedule link included enables patients to self-schedule a flu vaccine only visit, reducing friction for vaccine receipt. Additionally, the pre-commitment prompt with tailored reminders will test the principle of implementation intention (pre-planning the place and time of the flu vaccination) has been shown in other health behavior studies to improve follow-through.

For the primary analysis, the primary outcome will be the patient's end of flu season vaccination status. Intervention effects will be assessed using mixed effects log-binomial models. Models will contain terms for messaging modality (text v. portal v. none), pre-appointment reminders (sent v. not sent), and pre-commitment prompt (sent v. not sent).

The portal-based pre-commitment prompt will be sent in September of 2022. The R/R text and portal reminder messages and pre-appointment reminders and will begin in October of 2022.

02

Conditions studied

  • Influenza
  • Respiratory Tract Infections

Keywords

  • Reminder Recall (R/R)
  • Influenza Vaccine
  • Electronic Health Record
  • Text Message
  • Vaccine
03

In context

Influenza, Human

2,214 studies on the registry are indexed under Influenza, Human; 163 are open to participants now.

This study's enrollment of 262,085 is above the median of 238 across 1,853 interventional studies indexed under Influenza, Human.

Browse Influenza, Human studies →

Lead sponsor

University of California, Los Angeles is the lead sponsor of 1,142 studies on the registry; 192 are open to participants now.

Of its 91 completed or terminated interventional studies of FDA-regulated products, 66 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Active Portal Users A patient within the UCLA Health System identified as a primary care patient per an internal algorithm

Exclusion criteria

Exclusion Criteria:

  • A patient within the UCLA Health System not identified as a primary care patient per an internal algorithm
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Participant)
Enrollment
262,085 participants (actual)

Study arms

  • Active comparator
    Text Fixed R/R Messages with Direct Appointment Schedule Link + Text Pre-Appointment Reminders

    Participants in this arm will receive up to 3 R/R messages by text. R/R message will be sent with a Direct Appointment Scheduling link and instructions to make a flu vaccine appointment. Participants will receive a Pre-Appointment Reminder via text when they schedule a visit during the study period.

    Behavioral: Text Fixed R/R Messages with Direct Appointment Schedule Link · Behavioral: Text Pre-Appointment Reminder

  • Active comparator
    Text Fixed R/R Messages with Direct Appointment Schedule Link

    Participants in this arm will receive up to 3 R/R messages by text. R/R message will be sent with a Direct Appointment Scheduling link and instructions to make a flu vaccine appointment.

    Behavioral: Text Fixed R/R Messages with Direct Appointment Schedule Link

  • Active comparator
    Portal Pre-Commitment Prompt, Tailored R/R Messages w/ Direct Scheduling + Pre-Appointment Reminders

    Participants in this arm will receive a pre-commitment prompt message by portal in September. Tailored R/R messages will be sent monthly by portal based on time and place selected by patients (up to 3). R/R message will be sent with a Direct Appointment Scheduling link and instructions to make a flu vaccine appointment. Participants will receive a Pre-Appointment Reminder advising them to ask their doctor for the flu vaccine at their upcoming appointment via portal when they schedule a visit during the study period.

    Behavioral: Portal Pre-Commitment Prompt with Tailored R/R Messages with Direct Appointment Schedule Link · Behavioral: Portal Pre-Appointment Reminder

  • Active comparator
    Portal Pre-Commitment Prompt with Tailored R/R Messages with Direct Appointment Schedule Link

    Participants in this arm will receive a pre-commitment prompt message by portal in September. Tailored R/R messages will be sent monthly based on time and place selected by patients (up to 3). R/R message will be sent with a Direct Appointment Scheduling link and instructions to make a flu vaccine appointment.

    Behavioral: Portal Pre-Commitment Prompt with Tailored R/R Messages with Direct Appointment Schedule Link

  • Active comparator
    Portal Fixed R/R Messages with Direct Appointment Schedule Link + Portal Pre-Appointment Reminder

    Participants in this arm will receive up to 3 R/R messages by portal. R/R message will be sent with a Direct Appointment Scheduling link and instructions to make a flu vaccine appointment. Participants will receive a Pre-Appointment Reminder advising them to ask their doctor for the flu vaccine at their upcoming appointment via portal when they schedule a visit during the study period.

    Behavioral: Portal Fixed R/R Messages with Direct Appointment Schedule Link · Behavioral: Portal Pre-Appointment Reminder

  • Active comparator
    Portal Fixed R/R Messages with Direct Appointment Schedule Link

    Participants in this arm will receive up to 3 R/R messages by portal. R/R message will be sent with a Direct Appointment Scheduling link and instructions to make a flu vaccine appointment.

    Behavioral: Portal Fixed R/R Messages with Direct Appointment Schedule Link

  • No intervention
    No R/R Message or Pre-Appointment Reminder

    Participants do not receive any flu vaccine R/R message or Pre-Appointment Reminder advising them to ask their doctor for the flu vaccine at their upcoming appointment during the specified flu season.

Interventions

  • BehavioralText Fixed R/R Messages with Direct Appointment Schedule Link

    Participants in this arm will receive up to 3 R/R messages by text. R/R message will be sent with a Direct Appointment Scheduling link and instructions to make a flu vaccine appointment.

  • BehavioralText Pre-Appointment Reminder

    Participants will receive a Pre-Appointment Reminder via text when they schedule a visit during the study period.

  • BehavioralPortal Pre-Commitment Prompt with Tailored R/R Messages with Direct Appointment Schedule Link

    Participants in this arm will receive a pre-commitment prompt message by portal in September. Tailored R/R messages will be sent monthly by portal based on time and place selected by patients (up to 3). R/R message will be sent with a Direct Appointment Scheduling link and instructions to make a flu vaccine appointment.

  • BehavioralPortal Fixed R/R Messages with Direct Appointment Schedule Link

    Participants in this arm will receive up to 3 R/R messages by portal. R/R message will be sent with a Direct Appointment Scheduling link and instructions to make a flu vaccine appointment.

  • BehavioralPortal Pre-Appointment Reminder

    Participants will receive a Pre-Appointment Reminder advising them to ask their doctor for the flu vaccine at their upcoming appointment via portal when they schedule a visit during the study period.

06

What researchers measure

Primary outcomes

  1. Number of Participants With Annual Influenza Vaccine Among Index Patients

    Percent of patients with annual influenza vaccination (between 9/1/22 - 4/1/23) among index patients. Outcomes will be assessed via vaccine data extraction from the electronic health record and external claims and pharmacy data. The index patients must also be an active UCLA Health MyChart user (\>= 1 login over the last 12 months from 8/1/22, excluding activity on the user's initial profile activation date). Individuals not affiliated with any primary care practice will be excluded from the primary analysis.

    Time frame: 6 months

  2. Number of Participants With Annual Influenza Vaccine Among Pediatric Index Patients

    Percent of patients with annual influenza vaccination (between 9/1/22 - 4/1/23) among pediatric index patients. Outcomes will be assessed via vaccine data extraction from the electronic health record and external claims and pharmacy data. The index patients must also be an active UCLA Health MyChart user (\>= 1 login over the last 12 months from 8/1/22, excluding activity on the user's initial profile activation date). Individuals not affiliated with any primary care practice will be excluded from the primary analysis.

    Time frame: 6 months

07

Results

Posted Aug 7, 2024

Participant flow

Participant flow — Overall Study
MilestoneText Fixed R/R Messages With Direct Appointment Schedule Link + Text Pre-Appointment RemindersText Fixed R/R Messages With Direct Appointment Schedule LinkPortal Pre-Commitment Prompt, Tailored R/R Messages w/ Direct Scheduling + Pre-Appointment RemindersPortal Pre-Commitment Prompt With Tailored R/R Messages With Direct Appointment Schedule LinkPortal Fixed R/R Messages With Direct Appointment Schedule Link + Portal Pre-Appointment ReminderPortal Fixed R/R Messages With Direct Appointment Schedule LinkNo R/R Message or Pre-Appointment Reminder
Started43682436682188121876218642185787257
Completed43682436682188121876218642185787257
Not completed0000000

Outcome measures

PrimaryNumber of Participants With Annual Influenza Vaccine Among Index Patients

Percent of patients with annual influenza vaccination (between 9/1/22 - 4/1/23) among index patients. Outcomes will be assessed via vaccine data extraction from the electronic health record and external claims and pharmacy data. The index patients must also be an active UCLA Health MyChart user (\>= 1 login over the last 12 months from 8/1/22, excluding activity on the user's initial profile activation date). Individuals not affiliated with any primary care practice will be excluded from the primary analysis.

Time frame:
6 months
Reported as:
Count of participants · Participants
Number of Participants With Annual Influenza Vaccine Among Index Patients
ParticipantsText Fixed R/R Messages With Direct Appointment Schedule Link + Text Pre-Appointment RemindersText Fixed R/R Messages With Direct Appointment Schedule LinkPortal Pre-Commitment Prompt, Tailored R/R Messages w/ Direct Scheduling + Pre-Appointment RemindersPortal Pre-Commitment Prompt With Tailored R/R Messages With Direct Appointment Schedule LinkPortal Fixed R/R Messages With Direct Appointment Schedule Link + Portal Pre-Appointment ReminderPortal Fixed R/R Messages With Direct Appointment Schedule LinkNo R/R Message or Pre-Appointment Reminder
Number of Participants With Annual Influenza Vaccine Among Index Patients20689205701037410317103691030841166
Statistical analysis
  • Portal Pre-Commitment Prompt, Tailored R/R Messages w/ Direct Scheduling + Pre-Appointment Reminders vs Portal Pre-Commitment Prompt With Tailored R/R Messages With Direct Appointment Schedule Link vs Portal Fixed R/R Messages With Direct Appointment Schedule Link + Portal Pre-Appointment Reminder vs Portal Fixed R/R Messages With Direct Appointment Schedule Link vs No R/R Message or Pre-Appointment Reminder · Adjusted risk ratio: 0.99 · 95% CI 0.98 to 1.01Adjusted risk ratio. These results compare arms which received portal (any type) reminder/recall messages to the arm receiving no reminder/recall messages (control).
  • Text Fixed R/R Messages With Direct Appointment Schedule Link + Text Pre-Appointment Reminders vs Text Fixed R/R Messages With Direct Appointment Schedule Link vs No R/R Message or Pre-Appointment Reminder · Adjusted risk ratio: 1.00 · 95% CI 0.98 to 1.01Adjusted risk ratio. These results compare arms which received text (any type) reminder/recall messages to the arm receiving no reminder/recall messages (control).
  • Text Fixed R/R Messages With Direct Appointment Schedule Link + Text Pre-Appointment Reminders vs Portal Pre-Commitment Prompt, Tailored R/R Messages w/ Direct Scheduling + Pre-Appointment Reminders vs Portal Fixed R/R Messages With Direct Appointment Schedule Link + Portal Pre-Appointment Reminder vs No R/R Message or Pre-Appointment Reminder · Adjusted risk ratio: 1.01 · 95% CI 1.00 to 1.02Adjusted risk ratio. These results compare arms which received pre-appointment reminder/recall messages (portal and text) to the arm receiving no reminder/recall messages (control).
  • Portal Pre-Commitment Prompt, Tailored R/R Messages w/ Direct Scheduling + Pre-Appointment Reminders vs Portal Pre-Commitment Prompt With Tailored R/R Messages With Direct Appointment Schedule Link vs No R/R Message or Pre-Appointment Reminder · Adjusted risk ratio: 1.00 · 95% CI 0.99 to 1.01Adjusted risk ratio. These results compare arms which received a tailored reminder/recall messages based on their responses to a pre-commitment questionnaire (any type) to the arm receiving no reminder/recall messages (control).
PrimaryNumber of Participants With Annual Influenza Vaccine Among Pediatric Index Patients

Percent of patients with annual influenza vaccination (between 9/1/22 - 4/1/23) among pediatric index patients. Outcomes will be assessed via vaccine data extraction from the electronic health record and external claims and pharmacy data. The index patients must also be an active UCLA Health MyChart user (\>= 1 login over the last 12 months from 8/1/22, excluding activity on the user's initial profile activation date). Individuals not affiliated with any primary care practice will be excluded from the primary analysis.

Time frame:
6 months
Reported as:
Count of participants · Participants
Number of Participants With Annual Influenza Vaccine Among Pediatric Index Patients
ParticipantsText Fixed R/R Messages With Direct Appointment Schedule Link + Text Pre-Appointment RemindersText Fixed R/R Messages With Direct Appointment Schedule LinkPortal Pre-Commitment Prompt, Tailored R/R Messages w/ Direct Scheduling + Pre-Appointment RemindersPortal Pre-Commitment Prompt With Tailored R/R Messages With Direct Appointment Schedule LinkPortal Fixed R/R Messages With Direct Appointment Schedule Link + Portal Pre-Appointment ReminderPortal Fixed R/R Messages With Direct Appointment Schedule LinkNo R/R Message or Pre-Appointment Reminder
Number of Participants With Annual Influenza Vaccine Among Pediatric Index Patients2132211410681082109010634245

Adverse events

Collected over We did not collect information regarding adverse events.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Text Fixed R/R Messages With Direct Appointment Schedule Link + Text Pre-Appointment Reminders———
Text Fixed R/R Messages With Direct Appointment Schedule Link———
Portal Pre-Commitment Prompt, Tailored R/R Messages w/ Direct Scheduling + Pre-Appointment Reminders———
Portal Pre-Commitment Prompt With Tailored R/R Messages With Direct Appointment Schedule Link———
Portal Fixed R/R Messages With Direct Appointment Schedule Link + Portal Pre-Appointment Reminder———
Portal Fixed R/R Messages With Direct Appointment Schedule Link———
No R/R Message or Pre-Appointment Reminder———

Baseline characteristics

Age, Customized
Age, Customized(Participants)Text Fixed R/R Messages With Direct Appointment Schedule Link + Text Pre-Appointment RemindersText Fixed R/R Messages With Direct Appointment Schedule LinkPortal Pre-Commitment Prompt, Tailored R/R Messages w/ Direct Scheduling + Pre-Appointment RemindersPortal Pre-Commitment Prompt With Tailored R/R Messages With Direct Appointment Schedule LinkPortal Fixed R/R Messages With Direct Appointment Schedule Link + Portal Pre-Appointment ReminderPortal Fixed R/R Messages With Direct Appointment Schedule LinkNo R/R Message or Pre-Appointment ReminderTotal
<18 years409641292065204620282079823824681
18-64 years31012311061558715481156531551462084186437
65+ years8574843342294349418342641693550967
Sex/Gender, Customized
Sex/Gender, Customized(Participants)Text Fixed R/R Messages With Direct Appointment Schedule Link + Text Pre-Appointment RemindersText Fixed R/R Messages With Direct Appointment Schedule LinkPortal Pre-Commitment Prompt, Tailored R/R Messages w/ Direct Scheduling + Pre-Appointment RemindersPortal Pre-Commitment Prompt With Tailored R/R Messages With Direct Appointment Schedule LinkPortal Fixed R/R Messages With Direct Appointment Schedule Link + Portal Pre-Appointment ReminderPortal Fixed R/R Messages With Direct Appointment Schedule LinkNo R/R Message or Pre-Appointment ReminderTotal
Female25015248201249112474123171242049812149349
Male1864918827937893909536943037418112628
Other00001001
Unknown1821121210727107
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Text Fixed R/R Messages With Direct Appointment Schedule Link + Text Pre-Appointment RemindersText Fixed R/R Messages With Direct Appointment Schedule LinkPortal Pre-Commitment Prompt, Tailored R/R Messages w/ Direct Scheduling + Pre-Appointment RemindersPortal Pre-Commitment Prompt With Tailored R/R Messages With Direct Appointment Schedule LinkPortal Fixed R/R Messages With Direct Appointment Schedule Link + Portal Pre-Appointment ReminderPortal Fixed R/R Messages With Direct Appointment Schedule LinkNo R/R Message or Pre-Appointment ReminderTotal
American Indian or Alaska Native606742424226160439
Asian273928531427139013811443561516848
Black1334135765465270465127288080
Native Hawaiian or Other Pacific Islander43523522283696312
White or Caucasian144251471772867350726873002911887464
Other402238571970188719181894781723365
Multiracial1894198197897210181006390611755
Unknown1916518784948995619505950137817113822
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Text Fixed R/R Messages With Direct Appointment Schedule Link + Text Pre-Appointment RemindersText Fixed R/R Messages With Direct Appointment Schedule LinkPortal Pre-Commitment Prompt, Tailored R/R Messages w/ Direct Scheduling + Pre-Appointment RemindersPortal Pre-Commitment Prompt With Tailored R/R Messages With Direct Appointment Schedule LinkPortal Fixed R/R Messages With Direct Appointment Schedule Link + Portal Pre-Appointment ReminderPortal Fixed R/R Messages With Direct Appointment Schedule LinkNo R/R Message or Pre-Appointment ReminderTotal
Hispanic or Latino5316534226712662268026811069532047
Not Hispanic or Latino31128311661559715639155791559362246186948
Unknown7238716036133575360535831431643090
Primary Language
Primary Language(Participants)Text Fixed R/R Messages With Direct Appointment Schedule Link + Text Pre-Appointment RemindersText Fixed R/R Messages With Direct Appointment Schedule LinkPortal Pre-Commitment Prompt, Tailored R/R Messages w/ Direct Scheduling + Pre-Appointment RemindersPortal Pre-Commitment Prompt With Tailored R/R Messages With Direct Appointment Schedule LinkPortal Fixed R/R Messages With Direct Appointment Schedule Link + Portal Pre-Appointment ReminderPortal Fixed R/R Messages With Direct Appointment Schedule LinkNo R/R Message or Pre-Appointment ReminderTotal
English42617426052133421282213302128585147255600
Spanish4574562192342552398902750
Other54954330632926130010983386
Unknown596422311833122349
Primary Insurance Class
Primary Insurance Class(Participants)Text Fixed R/R Messages With Direct Appointment Schedule Link + Text Pre-Appointment RemindersText Fixed R/R Messages With Direct Appointment Schedule LinkPortal Pre-Commitment Prompt, Tailored R/R Messages w/ Direct Scheduling + Pre-Appointment RemindersPortal Pre-Commitment Prompt With Tailored R/R Messages With Direct Appointment Schedule LinkPortal Fixed R/R Messages With Direct Appointment Schedule Link + Portal Pre-Appointment ReminderPortal Fixed R/R Messages With Direct Appointment Schedule LinkNo R/R Message or Pre-Appointment ReminderTotal
Commercial30710307191540415291155391539161523184577
Group Health Plan808038404745174504
International Payor71169362668
Medi-Cal88191643846743046318695464
Medicare5366537626182690252926861058331848
Package Billing02012038
Tricare2762681421451481375801696
UCLA Managed Care5756566129072919286528001124334151
Other54258029128826729211203380
Unknown645537263437136389
08

Study locations

1 site
  • University of California, Los Angeles
    Los Angeles, California 99095, United States
09

References and documents

Study documents

  • Study protocol · Aug 18, 2022
  • Statistical analysis plan · Aug 18, 2022

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05525494
Lead sponsor
University of California, Los Angeles
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
Responsible party
Peter G Szilagyi, MD MPH (Executive Vice Chair, Vice Chair for Research, UCLA David Geffen School of Medicine, Department of Pediatrics, University of California, Los Angeles, University of California, Los Angeles) — Principal investigator
First posted
Sep 1, 2022
Start date
Sep 7, 2022
Primary completion
Apr 1, 2023
Completion
Apr 1, 2023
Results posted
Aug 7, 2024
Last update
Aug 7, 2024

Study contacts

Peter Szilagyi, MD, MPH
principal investigator · University of California, Los Angeles

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion